[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-459497-105":59,"doc-detail-459497-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","refractory-antibody-mediated-rejection-after-high-emergency-lung-transplantation-for-dermatomyositis-with-anti-mda5-antibody-a-case-report","Refractory antibody-mediated rejection after high-emergency lung transplantation for dermatomyositis with anti-MDA5 antibody - a case report","","Case Report in the journal Clin Transplant Res documents a 25-year-old woman with amyopathic anti-MDA5 positive dermatomyositis who underwent emergency double lung transplantation for rapidly progressive interstitial lung disease. After surgery, she developed acute antibody-mediated rejection characterized by rising donor-specific anti-HLA antibodies despite repeated immunosuppressive regimens. Rescue therapy used imlifidase, an IgG endopeptidase, to manage refractory AMR and underscores the post-transplant complexity and need for dedicated clinical trials.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/refractory-antibody-mediated-rejection-after-high-emergency-lung-transplantation-for-dermatomyositis-with-anti-mda5-antibody-a-case-report/459497/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/refractory-antibody-mediated-rejection-after-high-emergency-lung-transplantation-for-dermatomyositis-with-anti-mda5-antibody-a-case-report/459497.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What condition led to the high-emergency lung transplantation?","Question",{"text":112,"@type":113},"A 25-year-old woman with amyopathic anti-MDA5 positive dermatomyositis complicated by rapidly progressive interstitial lung disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What complication occurred after transplantation?",{"text":117,"@type":113},"She developed acute antibody-mediated rejection with a marked increase in donor-specific anti-HLA antibodies despite multiple immunosuppressive treatments.",{"name":119,"@type":110,"acceptedAnswer":120},"How was refractory antibody-mediated rejection managed?",{"text":121,"@type":113},"An experimental rescue strategy with imlifidase (an IgG endopeptidase) was used after standard therapies failed.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},459497,1791099356,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Case Report  \nClin Transplant Res 2025;39:378-383 [https://doi.org/10.4285/ctr.25.0034](https://doi.org/10.4285/ctr.25.0034)  \npISSN 3022-6783 eISSN 3022-7712  \nReceived May 15, 2025  \nRevised July 7, 2025  \nAccepted July 15, 2025  \nCorresponding author: Vincent Bunel Department of Pneumology, Allergology and Lung Transplantation, Bichat Hospital AP-HP, Paris-Cite University, 46 Rue Henri Huchard, Paris 75018, France [E-mail:](E-mail: vincent.bunel@aphp.fr)[ vincent.bunel@aphp.fr](E-mail: vincent.bunel@aphp.fr)  \n© The Korean Society for Transplantation This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/](http://creativecommons.org/licenses/)[ ](http://creativecommons.org/licenses/)[by-nc/4.0/](by-nc/4.0/)) [which](which) permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nRefractory antibody-mediated rejection after high-emergency lung transplantation fordermatomyositis with anti-MDA5 antibody:  \na case report  \nLouise Chantelot1, Domitille Mouren1, Jean-Luc Taupin2, Aurélie Cazes3, Jonathan Messika1, Cendrine Godet1, Mathilde Salpin1, Gaelle Weisenburger1, Brice Lortat-Jacob4, Pierre Mordant5, Jean-François Alexandra6, Raphael Borie1, Chloé Comarmond7, Yves Allenbach8, Yurdagül Uzunhan9, Hervé Mal1, Antoine Roux10, Vincent Bunel1  \n1Department of Pneumology, Allergology and Lung Transplantation, Bichat Hospital AP-HP, Paris-Cite University, Paris, France  \n2Department of Immunology and Histocompatibility, Saint Louis Hospital AP-HP, Paris-Cite University, Paris, France 3Department of Pathology, Bichat Hospital AP-HP, Paris-Cite University, Paris, France  \n4Department of Anaesthesiology and Critical Care Medicine, Bichat Claude Bernard Hospital, Université Paris Cité, Paris, France  \n5Department of Thoracic Surgery, Bichat Claude Bernard Hospital, Université Paris Cité, Paris, France 6Department of Internal Medicine, Bichat Hospital AP-HP, Paris-Cite University, Paris, France  \n7Department of Internal Medicine and Clinical Immunology, Lariboisière Hospital, Paris-Cite University, Paris, France  \n8Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France  \n9Department of Pneumology, Avicenne Hospital AP-HP, Sorbonne Paris Nord University, Bobigny, France 10Department of Pneumology, Foch Hospital, Suresnes, France  \nThis case report describes a female with amyopathic anti-MDA5+ dermatomyositis who underwent emergency double lung transplantation due to rapidly progressive interstitial lung disease. Following transplantation, she developed acute antibody-mediated rejection (AMR) . Despite multiple rounds of immunosuppressive therapy, her condition continued to deteriorate, and her donor-specific anti-human leukocyte antigen antibody levels increased markedly. An experimental treatment, imlifidase—an immunoglobulin G endopeptidase—was employed as a rescue therapy. This case highlights the complexity of posttransplant management of AMR and emphasizes the need for dedicated clinical trials to provide additional data.  \nKeywords: Lung transplantation; Emergency; Antibody-mediated rejection; Dermatomyositis; Anti-MDA5 antibody  \n378 [https://doi.org/10.4285/ctr.25.0034](https://doi.org/10.4285/ctr.25.0034)  \nChantelot L et al. Refractory antibody-mediated rejection lung transplantation  \nHIGHLIGHTS  \n• This case report illustrates the challenge of managing antibody-mediated rejection (AMR) following emergency lung transplantation in a patient with anti-MDA5 dermatomyositis.  \n• Despite aggressive immunosuppressive therapy, AMR proved refractory, necessitating the use of imlifidase asa rescue strategy.  \n• The case underscores the difficulty in managing refractory AMR, highlighting the absence of established guidelines or data to inform therapeutic decisions.  \nINTRODUCTION  \nLung transplan","cbCaihTFWc5kFsXd","https://ap.wps.com/l/cbCaihTFWc5kFsXd","pdf",788645,"English","# Highlights\n# Introduction\n# Case Report","[{\"question\":\"What condition led to the high-emergency lung transplantation?\",\"answer\":\"A 25-year-old woman with amyopathic anti-MDA5 positive dermatomyositis complicated by rapidly progressive interstitial lung disease.\"},{\"question\":\"What complication occurred after transplantation?\",\"answer\":\"She developed acute antibody-mediated rejection with a marked increase in donor-specific anti-HLA antibodies despite multiple immunosuppressive treatments.\"},{\"question\":\"How was refractory antibody-mediated rejection managed?\",\"answer\":\"An experimental rescue strategy with imlifidase (an IgG endopeptidase) was used after standard therapies failed.\"}]","Refractory antibody-mediated rejection after high-emergency lung transplantation for dermatomyositis with anti-MDA5 antibody - a case report | PDF",1790756051,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/73fa6e7b513041476547f12b7b04b49a.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/af88fc82e7618b6f4368e95a3261e772.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1a59109decc357a7cd5b413c59ba2be9.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/4a0e71cac6bb6bd8bc8ba33ea8f912a9.webp",980,1306]